VJHemOnc is committed to improving our service to you

CAR-T ICU 2019 | Dealing with the issue of sepsis vs. CRS in CAR-T patients

VJHemOnc is committed to improving our service to you

Sigurdur Sigurdsson

Sigurdur Sigurdsson, of the Icelandic Heart Association, Kopavogur, Iceland, discusses the issue of distinguishing sepsis and cytokine release syndrome (CRS) in patients treated with CAR-T therapy. He highlightsthe importance of treatment with antibiotics in case of sepsis. This interview took place at the CAR-T Cell Therapy and the ICU 2019 meeting in London, UK, which was organized by EuroCARTForce.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter